Noninterventional Open-Label Trial Investigating the Efficacy and Safety of Ectoine Containing Nasal Spray in Comparison with Beclomethasone Nasal Spray in Patients with Allergic Rhinitis
Figure 10
Assessment of efficacy of treatments in groups 1 and 2 over a period of 14 days (mean). . Lines within the box mark the median; the upper and lower ends of the box indicate the 75th and 25th percentiles, respectively. Whiskers above and below the box indicate the 90th and 10th percentiles. Dots (•) represent outlying points.